The funds will support the progression of MindRank’s pipeline, which is heavily dominated by obesity indications.

Five innovative companies are challenging industry norms across cancer treatment, agriculture, antibiotics, cybersecurity, ...

July 10 () - Apnimed, a late-stage clinical pharmaceutical company, filed for an initial ‌public offering in the U. The biotech sector has staged a notable comeback as ​fresh capital flows back into ...

Greenland Mines (NASDAQ: GRML) announced that IP Australia has granted Australian Patent No. 2023252508 covering gene ...

It's been a volatile year for the company, but don't let that scare you away.

After more than three decades in business, a longstanding Back Bay spa and salon is closing its doors for good.

This week's Optimizer delves into the gaming community's reaction to biohacker Bryan Johnson revealing his diagnosis of autoimmune gastritis.

VERAXA Biotech AG (NASDAQ: VRXA; 'VERAXA”), an emerging leader in designing novel cancer therapies, today announced the appointment of Carl von Halem as Interim Chief Financial Officer. He succeeds ...

VERAXA Biotech AG (NASDAQ: VRXA; "VERAXA"), an emerging leader in designing novel cancer therapies, today announced the appointment of Carl von Halem as Interim Chief ...

Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata ("AA") and other autoimmune and inflammatory diseases, ...

Eugenio Battaglia is a biotechnology researcher who has worked with the European Union to develop frameworks for responsible ...